[1] 易祥华,孔 洁,朱美芳,等. 原发性肺隐球菌病的病理诊断和超微结构观察[J]. 中华病理学杂志,2004,33(5):424-428.
[2] Shibuya K,Hirata A,Omuta J,et al. Granuloma and cryptococcosis[J]. J Infect Chemother,2005,11(3):115-122.
[3] Lortholary O,Nunez H,Brauner MW,et al. Pulmonary cryptococcosis[J]. Semin Respir Crit Care Med,2004,25(2):145-157.
[4] Yang CJ,Hwang JJ,Wang T H,et al. Clinical and radiographic presentations of pulmenary cryptococcosis in immunocompetent patients[J]. Scand J Infect Dis,2006,38(9):788-793.
[5] Hung MS,Tsai YH,Lee CH,et al. Pulmonary cryptococcosis: Clinical, radiographical and serological markers of dissemination[J]. Respirology,2008,13(2):247-251.
[6] 张 缨,宗晓福,李祥周,等. 肺隐球菌病17例临床病理分析[J]. 临床与实验病理学杂志,2009,25(5):485-488.
[7] Shirley R,Baddley JW. Cryptococcal lung disease[J]. Curr Opin Pulm Med,2009,15(3):254-260.
[8] Chu HQ,Li HP,He GJ,et al. Analysis of 23 cases of pulmonary cryptococcosis[J]. Chin Med J,2004,117(9):1425-1427.
[1]谢 红,谷 伟.联合吸入治疗慢性阻塞性肺病稳定期患者的疗效观察[J].医学研究与战创伤救治(原医学研究生学报),2011,13(04):330.
XIE Hong,GU Wei..The curative effects of ipratropium bromide inhalation aerosol combined with salmeterol fluticasone propionate inhalation powder on chronic obstructive pulmonary disease patients in stable phase[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2011,13(01):330.